Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 27 (CICP27) is a pseudogene found on chromosome 1 (ENSEMBL ID: ENSG00000233750, Entrez ID: 100420257)[1][3]. Pseudogenes are genomic DNA sequences homologous to known genes but have lost their typical protein-coding capability due to mutations such as frameshifts or premature stop codons[2][6]. CICP27 shares homology with the functional capicua transcriptional repressor gene but is presumed nonfunctional, lacking a protein product and exhibiting no established biological or disease-related activity. There are no current reports of therapeutic interest, nor is CICP27 known to serve as a clinically relevant biomarker or drug target[3][1][2]. If you are searching for protein-coding targets relevant to therapy, CICP27 should not be classified as such due to its pseudogene status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 27 (CICP27).